Pharmaceutical

Light Horse emerges with $62m and Novartis partnership worth up to $1bn

Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

Jan 12, 2025 - 06:00
Light Horse emerges with $62m and Novartis partnership worth up to $1bn
Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.
Read the original article

Tags:

Previous Article

A2 Biotherapeutics raises $80m to advance CAR-T therapies for solid tumours

Next Article

Coave Therapeutics raises $33m in funding to advance ALIGATER platform

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Bayer’s promising menopause drug trial results highlight growing interest in long-neglected condition

STAT+: Bayer’s promising menopause drug trial results h...

Jan 10, 2024

STAT+: UnitedHealth Group now employs or is affiliated with 10% of all physicians in the U.S.

STAT+: UnitedHealth Group now employs or is affiliated ...

Nov 29, 2023

BGB-10188 by BeiGene for Fallopian Tube Cancer: Likelih...

Oct 29, 2023